BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.2.3.1//EN
BEGIN:VEVENT
UID:343@siliconvalleyons.org
DTSTART:20250410T023000Z
DTEND:20250410T040000Z
DTSTAMP:20250310T205657Z
URL:https://www.siliconvalleyons.org/events/her2-expression-informs-eligib
 ility-for-enhertu-in-2l-her2-mbc-discussion-april-9th/
SUMMARY:HER2 Expression Informs Eligibility for ENHERTU® in 2L HER2+ mBC D
 iscussion - April 9th
DESCRIPTION:On behalf of Daiichi Sankyo\, Inc. and AstraZeneca\, we cordial
 ly invite you to join us for an informative\, expert-led discussion explor
 ing the clinical significance of HER2 expression in eligible patients with
  mBC. ENHERTU is a HER2-directed antibody and topoisomerase inhibitor conj
 ugate indicated for the treatment of adult patients with unresectable or m
 etastatic: HER2-positive (IHC 3+ or ISH positive) breast cancer who have r
 eceived a prior anti-HER2-based regimen either 1) in the metastatic settin
 g\, or 2) in the neoadjuvant or adjuvant setting and have developed diseas
 e recurrence during or within six months of completing therapy.\n\nLearnin
 g Objectives:\n\n 	Examine the unmet need for patients with HER2+ mBC\n 	R
 eview the clinical efficacy and safety data of an ENHERTU clinical trial i
 n HER2+ mBC\n 	Learn about dosage and administration of ENHERTU\n\nDate: A
 pr 9th\, 2025\, 6:30 PM - 8:00 PM\, Pacific Standard Time\n\nFaculty: Niti
 n Rohatgi\, MD\, Sutter Cancer Center\, Sacramento\n\nLocation: Be Steak A
 \, 1887 South Bascom Avenue\, Campbell\, CA 95008\n\nRSVP: Joyce Lew\, (41
 5) 987-8862 or By: 4/1/2025\n\nClick here to view the full event flyer
LOCATION:Be Steak A\, 1887 South Bascom Avenue\, Campbell\, CA\, 95008\, Un
 ited States
GEO:37.287318;-121.934698
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=1887 South Bascom Avenue\, 
 Campbell\, CA\, 95008\, United States;X-APPLE-RADIUS=100;X-TITLE=Be Steak 
 A:geo:37.287318,-121.934698
END:VEVENT
END:VCALENDAR